Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

MLA

Alan P. Kumar, et al. Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-Negative Breast Cancers. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0a0f8a276b53f71a91851a1a8a4f6ab9&authtype=sso&custid=ns315887.

APA

Alan P. Kumar, Lina H.K. Lim, Gautam Sethi, Peter E. Lobie, Louis Gaboury, Joo I. Park, Boon C. Goh, Henry Yang, Han M. Shen, Frank Arfuso, Sung W. Shin, Tuan Z. Tan, Muthu K. Shanmugam, Ramar P. Samy, Einas Yousef, Pei F. Koh, Ji E. Kim, Suruchi Arora, Madhu M. Kanchi, … Luxi Chen. (2023). Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.

Chicago

Alan P. Kumar, Lina H.K. Lim, Gautam Sethi, Peter E. Lobie, Louis Gaboury, Joo I. Park, Boon C. Goh, et al. 2023. “Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-Negative Breast Cancers,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0a0f8a276b53f71a91851a1a8a4f6ab9&authtype=sso&custid=ns315887.